{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:56:56Z","timestamp":1794049016002,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12072-020-10089-z","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T02:02:34Z","timestamp":1600480954000},"page":"191-201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7776-6069","authenticated-orcid":false,"given":"Y.","family":"Lapidot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Amir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ben-Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Veitsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Cohen-Ezra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Davidov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bradichevski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Ben-Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Safran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,19]]},"reference":[{"key":"10089_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1055\/s-0037-1608801","volume":"37","author":"J Hov","year":"2017","unstructured":"Hov J, Karlsen T. The microbiome in primary sclerosing cholangitis: current evidence and potential concepts. Semin Liver Dis. 2017;37:314\u2013331","journal-title":"Semin Liver Dis"},{"key":"10089_CR2","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/hep.20457","volume":"40","author":"M F\u00e4rkkil\u00e4","year":"2004","unstructured":"F\u00e4rkkil\u00e4 M, Karvonen A-L, Nurmi H, Nuutinen H, Taavitsainen M, Pikkarainen P, et al. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Hepatology. 2004;40:1379\u20131386","journal-title":"Hepatology"},{"key":"10089_CR3","first-page":"293","volume":"14","author":"JH Tabibian","year":"2018","unstructured":"Tabibian JH, Ali AH, Lindor KD. Primary sclerosing cholangitis, part 1: epidemiology, etiopathogenesis, clinical features, and treatment. Gastroenterol Hepatol. 2018;14:293\u2013304","journal-title":"Gastroenterol Hepatol"},{"key":"10089_CR4","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/hep.27819","volume":"62","author":"JS Bajaj","year":"2015","unstructured":"Bajaj JS, Betrapally NS, Hylemon PB, Heuman DM, Daita K, White MB, Unser A, et al. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology. 2015;62:1260\u20131271","journal-title":"Hepatology"},{"key":"10089_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/dnares\/dst037","volume":"21","author":"HS Said","year":"2014","unstructured":"Said HS, Suda W, Nakagome S, Chinen H, Oshima K, Kim S, Kimura R, et al. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers. DNA Res. 2014;21:15\u201325","journal-title":"DNA Res"},{"key":"10089_CR6","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1136\/gutjnl-2017-314814","volume":"67","author":"B Flemer","year":"2018","unstructured":"Flemer B, Warren RD, Barrett MP, Cisek K, Das A, Jeffery IB, Hurley E, et al. The oral microbiota in colorectal cancer is distinctive and predictive. Gut. 2018;67:1454\u20131463","journal-title":"Gut"},{"key":"10089_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ajg.2015.112","volume":"110","author":"KD Lindor","year":"2015","unstructured":"Lindor KD, Kowdley KV, Harrison EM, American College of Gastroenterology. ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015;110:646\u2013659","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10089_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51(2):660\u2013678","journal-title":"Hepatology."},{"key":"10089_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","volume":"6","author":"A Dignass","year":"2012","unstructured":"Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, Mantzaris G, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohn\u2019s Colitis. 2012;6:965\u2013990","journal-title":"J Crohn\u2019s Colitis"},{"key":"10089_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.crohns.2009.12.003","volume":"4","author":"G Van Assche","year":"2010","unstructured":"Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, Ochsenk\u00fchn T, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis. J Crohn\u2019s Colitis. 2010;4:7\u201327","journal-title":"J Crohn\u2019s Colitis"},{"key":"10089_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1023\/A:1025634020718","volume":"18","author":"D Shahar","year":"2003","unstructured":"Shahar D, Shai I, Vardi H, Brener-Azrad A, Fraser D. Development of a semi-quantitative Food Frequency Questionnaire (FFQ) to assess dietary intake of multiethnic populations. Eur J Epidemiol. 2003;18:855\u2013861","journal-title":"Eur J Epidemiol"},{"key":"10089_CR12","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1093\/jn\/133.11.3625","volume":"133","author":"D Shahar","year":"2003","unstructured":"Shahar D, Fraser D, Shai I, Vardi H. Development of a Food Frequency Questionnaire (FFQ) for an elderly population based on a population survey. J Nutr. 2003;133:3625\u20133629","journal-title":"J Nutr"},{"issue":"3","key":"10089_CR13","doi-asserted-by":"publisher","first-page":"e00153","DOI":"10.1128\/mSystems.00153-20","volume":"5","author":"Y Lapidot","year":"2020","unstructured":"Lapidot Y, Amir A, Nosenko R, Uzan-Yulzari A, Veitsman E, Cohen-Ezra O, Davidov Y, et al. Alterations in the gut microbiome in the progression of cirrhosis to hepatocellular carcinoma. mSystems. 2020;5(3).e00153\u2013e00220","journal-title":"mSystems"},{"key":"10089_CR14","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ismej.2012.8","volume":"6","author":"JG Caporaso","year":"2012","unstructured":"Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, Owens SM, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6:1621\u20131624","journal-title":"ISME J"},{"issue":"8","key":"10089_CR15","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E \u200bBolyen","year":"2019","unstructured":"\u200bBolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u2013857","journal-title":"Nat Biotechnol."},{"key":"10089_CR16","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60","journal-title":"Genome Biol."},{"issue":"7","key":"10089_CR17","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/liv.14153","volume":"39","author":"M Kummen","year":"2019","unstructured":"Kummen M, Hov JR. The gut microbial influence on cholestatic liver disease. Liver Int. 2019;39(7):1186\u20131196","journal-title":"Liver Int."},{"key":"10089_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmet.2017.05.008","volume":"26","author":"TS Postler","year":"2017","unstructured":"Postler TS, Ghosh S. Understanding the Holobiont: how microbial metabolites affect human health and shape the immune system. Cell Metab. 2017;26:110\u2013130","journal-title":"Cell Metab"},{"issue":"2","key":"10089_CR19","first-page":"e00191","volume":"2","author":"A Amir","year":"2017","unstructured":"Amir A, McDonald D, Navas-Molina JA, Kopylova E, Morton JT, Xu ZZ, Kightley EP, et al. Deblur rapidly resolves single-nucleotide community sequence patterns. mSystems. 2017;2(2):e00191\u2013e00216","journal-title":"mSystems"},{"key":"10089_CR20","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cell.2018.08.047","volume":"174","author":"J Suez","year":"2018","unstructured":"Suez J, Zmora N, Zilberman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, Zur M, et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell. 2018;174:1406\u20131423.e16","journal-title":"Cell"},{"key":"10089_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcimb.2012.00004","volume":"2","author":"NO Kaakoush","year":"2012","unstructured":"Kaakoush NO, Mitchell HM. Campylobacter concisus\u2014a new player in intestinal disease. Front Cell Infect Microbiol. 2012;2:4","journal-title":"Front Cell Infect Microbiol"},{"key":"10089_CR22","doi-asserted-by":"publisher","first-page":"19355","DOI":"10.18632\/oncotarget.8466","volume":"7","author":"G Xie","year":"2016","unstructured":"Xie G, Wang X, Liu P, Wei R, Chen W, Rajani C, Hernandez BY, et al. Distinctly altered gut microbiota in the progression of liver disease. Oncotarget. 2016;7:19355\u201319366","journal-title":"Oncotarget"},{"issue":"2","key":"10089_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10096-008-0602-7","volume":"28","author":"DS Acton","year":"2009","unstructured":"Acton DS, Tempelmans Plat-Sinnige MJ, Van Wamel W, De Groot N, Van Belkum A. Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact? Eur J Clin Microbiol Infect Dis. 2009;28(2):115\u2013127","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10089_CR24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1177\/2050640618761703","volume":"6","author":"K Wijarnpreecha","year":"2018","unstructured":"Wijarnpreecha K, Panjawatanan P, Mousa OY, Cheungpasitporn W, Pungpapong S, Ungprasert P. Association between smoking and risk of primary sclerosing cholangitis: a systematic review and meta-analysis. United Eur Gastroenterol J. 2018;6:500\u2013508","journal-title":"United Eur Gastroenterol J"},{"key":"10089_CR25","first-page":"e5628","volume":"95","author":"Y Li","year":"2016","unstructured":"Li Y, Zhou L, Zhao X, Song W, Karunaratna N, Bangmao W. The importance of IgG4 screening in patients diagnosed with primary sclerosing cholangitis in the past: a case rediagnosed as IgG4-SC after 10 years. Med (United States). 2016;95:e5628","journal-title":"Med (United States)"},{"key":"10089_CR26","doi-asserted-by":"publisher","first-page":"e0185274","DOI":"10.1371\/journal.pone.0185274","volume":"12","author":"I Mashima","year":"2017","unstructured":"Mashima I, Theodorea CF, Thaweboon B, Thaweboon S, Scannapieco FA, Nakazawa F. Exploring the salivary microbiome of children stratified by the oral hygiene index. PLoS ONE. 2017;12:e0185274","journal-title":"PLoS ONE"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10089-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-020-10089-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10089-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T19:54:34Z","timestamp":1631994874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-020-10089-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,19]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10089"],"URL":"https:\/\/doi.org\/10.1007\/s12072-020-10089-z","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,19]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Lapidot Y, Amir A, Ben-Simon S, Veitsman E, Cohen-Ezra O, Davidov Y, Weiss P, Bradichevski T, Segev S, Koren O, Ben-Ari Z, Safran M authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. (Sheba medical center committee permit number 2530-15, Rambam medical center committee permit number 0651-16).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}